Related Experiment Videos
Methylthioadenosine phosphorylase activity in human erythrocytes
Summary
Researchers identified an enzyme, 5'-methylthioadenosine phosphorylase, in human red blood cells that breaks down 5'-methylthioadenosine into adenine. This enzyme
Area of Science:
- Biochemistry
- Human Physiology
- Enzymology
Background:
- 5 -methylthioadenosine is a byproduct of polyamine biosynthesis.
- Adenine is a crucial component of nucleic acids and energy carriers.
- Deficiency in adenine salvage pathways can lead to metabolic disorders.
Purpose of the Study:
- To identify and characterize an enzyme in human erythrocytes that degrades 5 -methylthioadenosine.
- To develop a rapid assay for quantifying 5 -methylthioadenosine phosphorylase activity.
- To investigate the role of this enzyme in purine metabolism, particularly in patients with adenine phosphoribosyltransferase deficiency.
Main Methods:
- High-performance liquid chromatography (HPLC) was used to develop a rapid assay for 5 -methylthioadenosine phosphorylase.
- Enzyme activity was measured in erythrocyte lysates from normal subjects and patients with purine metabolism disorders.
- A linked assay system was employed to assess the conversion of adenine to AMP.
Main Results:
- An enzyme, 5 -methylthioadenosine phosphorylase, capable of degrading 5 -methylthioadenosine to adenine was identified in human erythrocytes.
- The specific activity of this enzyme in normal subjects was determined to be 8.9 +/- 2.0 nmol . mg-1 Hb . h-1.
- Erythrocytes from patients with adenine phosphoribosyltransferase deficiency could not convert the produced adenine to AMP, unlike controls.
Conclusions:
- The identified enzyme plays a role in the catabolism of 5 -methylthioadenosine in human red blood cells.
- The findings support the hypothesis that endogenous adenine excretion in adenine phosphoribosyltransferase deficiency originates from 5 -methylthioadenosine, a byproduct of polyamine synthesis.
- This study provides insights into purine metabolism and its alterations in specific genetic disorders.